Liang Yu
Impact in
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Cholinesterase and Neurodegenerative Diseases
-
- Lung Cancer Treatments and Mutations
Papers in
- Pharmacology 19
- Microbial Natural Products and Biosynthesis 14
- Fungal Biology and Applications 10
- Cholinesterase and Neurodegenerative Diseases 4
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Kang Qin (3 shared papers)Xiaochun Zhang (2 shared papers)Helei Hou (2 shared papers)Hucheng Zhu (16 shared papers)Chunmei Chen (15 shared papers)Yonghui Zhang (9 shared papers)Weiguang Sun (8 shared papers)Jianping Wang (3 shared papers)
- Journals
- Phytochemistry (5 papers)Bioorganic Chemistry (3 papers)Medicine (2 papers)Journal of Natural Products (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Liang Yu
47 papers receiving 635 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 127
- Pulmonary and Respiratory Medicine 191
- Oncology 141
- Biotechnology 46
- Cancer Research 68
Countries citing papers authored by Liang Yu
This map shows the geographic impact of Liang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Yu more than expected).
Fields of papers citing papers by Liang Yu
This network shows the impact of papers produced by Liang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Yu. The network helps show where Liang Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Liang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 108 | |
| 2 | 2019 | 55 | |
| 3 | 2022 | 37 | |
| 4 | 2022 | 35 | |
| 5 | 2010 | 33 | |
| 6 | 2021 | 29 | |
| 7 | 2019 | 27 | |
| 8 | 2013 | 26 | |
| 9 | 2020 | 25 | |
| 10 | 2016 | 25 | |
| 11 | 2004 | 22 | |
| 12 | 2013 | 20 | |
| 13 | 2020 | 19 | |
| 14 | 2021 | 16 | |
| 15 | 2023 | 16 | |
| 16 | 2014 | 14 | |
| 17 | 2019 | 14 | |
| 18 | 2018 | 12 | |
| 19 | 2023 | 10 | |
| 20 | 2022 | 8 |
About Liang Yu
Liang Yu is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine, Organic Chemistry, Oncology and Surgery, having authored 54 papers that have together received 643 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (14 papers), Fungal Biology and Applications (10 papers), Chemical synthesis and alkaloids (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Marine Sponges and Natural Products (3 papers), Sinusitis and nasal conditions (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmacology (127 citations), Pulmonary and Respiratory Medicine (191 citations), Oncology (141 citations), Biotechnology (46 citations) and Cancer Research (68 citations). Liang Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Kang Qin, Xiaochun Zhang, Helei Hou, Hucheng Zhu, Chunmei Chen, Yonghui Zhang, Weiguang Sun, Jianping Wang, Yi Lv and Jingjuan Zhu. Their work appears in journals such as Phytochemistry, Bioorganic Chemistry, Medicine, Journal of Natural Products and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.